Back

Fluoroquinolone use and risk of aortic aneurysm: nationwide cohort study in Sweden

29 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters 7 - Best Posters in aortic disease Aortic Disease ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Bjorn Pasternak

Statens Serum Institut, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Foa' (Bologna, IT)
Abstract Slides
Presentation thumbnail
Doctor F. Morello (Turin, IT)
Abstract Slides
Presentation thumbnail
Doctor A. Guala (Barcelona, ES)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 7 - Best Posters in aortic disease

The Event

Event poster

ESC Congress 2017

29 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Risks and benefits of antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease: a nationwide cohort study
27 August 2023
thumbnail
Congress Session
Aortic disease - from arteritis to dissections
19 May 2025
thumbnail
Congress Presentation
The effect of doxycycline on abdominal aortic aneurysm growth: a meta-analysis.
27 August 2021
thumbnail
Congress Presentation
Hypertension in thoracic aortic aneurysm and dissection: considerations in the choice of antihypertensive agents for the long-term management
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources